[go: up one dir, main page]

CA2049655A1 - Composition pharmaceutique pour inhiber l'aggregation des plaquettes - Google Patents

Composition pharmaceutique pour inhiber l'aggregation des plaquettes

Info

Publication number
CA2049655A1
CA2049655A1 CA2049655A CA2049655A CA2049655A1 CA 2049655 A1 CA2049655 A1 CA 2049655A1 CA 2049655 A CA2049655 A CA 2049655A CA 2049655 A CA2049655 A CA 2049655A CA 2049655 A1 CA2049655 A1 CA 2049655A1
Authority
CA
Canada
Prior art keywords
pharmaceutical composition
platelet aggregation
alkyl group
lower alkyl
inhibiting platelet
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CA2049655A
Other languages
English (en)
Other versions
CA2049655C (fr
Inventor
Akio Odawara
Yasuhiko Sasaki
Sakae Murata
Hiroshi Narita
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Mitsubishi Tanabe Pharma Corp
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from JP2243728A external-priority patent/JPH078798B2/ja
Priority claimed from JP2243729A external-priority patent/JPH078799B2/ja
Application filed by Individual filed Critical Individual
Publication of CA2049655A1 publication Critical patent/CA2049655A1/fr
Application granted granted Critical
Publication of CA2049655C publication Critical patent/CA2049655C/fr
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/60—Salicylic acid; Derivatives thereof

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Nitrogen- Or Sulfur-Containing Heterocyclic Ring Compounds With Rings Of Six Or More Members (AREA)
CA002049655A 1990-09-17 1991-08-21 Composition pharmaceutique pour inhiber l'aggregation des plaquettes Expired - Fee Related CA2049655C (fr)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
JP243728/1990 1990-09-17
JP2243728A JPH078798B2 (ja) 1990-09-17 1990-09-17 血小板凝集抑制組成物
JP243729/1990 1990-09-17
JP2243729A JPH078799B2 (ja) 1990-09-17 1990-09-17 血小板凝集抑制組成物

Publications (2)

Publication Number Publication Date
CA2049655A1 true CA2049655A1 (fr) 1992-03-18
CA2049655C CA2049655C (fr) 1996-11-12

Family

ID=26536403

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002049655A Expired - Fee Related CA2049655C (fr) 1990-09-17 1991-08-21 Composition pharmaceutique pour inhiber l'aggregation des plaquettes

Country Status (9)

Country Link
US (1) US5387581A (fr)
EP (1) EP0476854B1 (fr)
KR (1) KR0145689B1 (fr)
AT (1) ATE106734T1 (fr)
CA (1) CA2049655C (fr)
DE (1) DE69102379T2 (fr)
DK (1) DK0476854T3 (fr)
ES (1) ES2057777T3 (fr)
FR (1) FR2666741B1 (fr)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2108832T3 (es) * 1992-10-23 1998-01-01 Tanabe Seiyaku Co Agente que mejora la circulacion periferica.
US5637582A (en) * 1992-10-23 1997-06-10 Tanabe Seiyaku Co., Ltd. Peripheral circulation improving agent
MA24512A1 (fr) * 1996-01-17 1998-12-31 Univ Vermont And State Agrienl Procede pour la preparation d'agents anticoagulants utiles dans le traitement de la thrombose
US20070190059A1 (en) * 1996-01-17 2007-08-16 Smithkline Beecham Corporation Antithrombotic agents
US20030235587A1 (en) * 1998-08-07 2003-12-25 Feuerstein Giora Z. Anticoagulant agents useful in treatment of thrombosis
US6010911A (en) * 1997-04-30 2000-01-04 Medtronic, Inc. Apparatus for performing a heparin-independent high sensitivity platelet function evaluation technique
BR0015872A (pt) * 2000-05-15 2004-08-03 Smithkline Beecham Corp Agentes antitrombóticos
EP1747451B1 (fr) 2004-05-17 2011-11-02 Medtronic, Inc. Systeme de determination de l'heparine selon les points d'intervention

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4567175A (en) * 1983-06-03 1986-01-28 Tanabe Seiyaku Co., Ltd. 8-Chloro-1,5-benzothiazepine derivatives
US4590188A (en) * 1984-02-18 1986-05-20 Tanabe Seiyaku Co., Ltd. 1,5-benzothiazepine derivatives and their pharmaceutical use
US4594342A (en) * 1984-04-10 1986-06-10 Tanabe Seiyaku Co., Ltd. 1,5-benzothiazepine derivative
FR2589358B1 (fr) * 1985-07-30 1987-12-04 Synthelabo Compositions pharmaceutiques a base de diltiazem et d'aspirine
DE3626097A1 (de) * 1986-07-31 1988-02-11 Goedecke Ag Wirkstoffkombination enthaltend diltiazem und acetylsalicylsaeure

Also Published As

Publication number Publication date
KR920005986A (ko) 1992-04-27
EP0476854B1 (fr) 1994-06-08
FR2666741A1 (fr) 1992-03-20
DE69102379T2 (de) 1994-09-29
US5387581A (en) 1995-02-07
DE69102379D1 (de) 1994-07-14
ES2057777T3 (es) 1994-10-16
KR0145689B1 (ko) 1998-08-17
FR2666741B1 (fr) 1993-01-08
DK0476854T3 (da) 1994-07-11
CA2049655C (fr) 1996-11-12
EP0476854A1 (fr) 1992-03-25
ATE106734T1 (de) 1994-06-15

Similar Documents

Publication Publication Date Title
EP0150937A3 (en) Dihydropyridazinones
AU591640B2 (en) Quinolonecarboxylic acid derivatives
EP1095654A3 (fr) Utilisation du raloxifene et de ses analogues dans la fabrication d'un medicament pour l'Inhibition de l'oxidation de LDL et de l'athérosclérose
IL114785A0 (en) Pyrrolocarbazoles their preparation and pharmaceutical compositions containing them
AU2868689A (en) Use of 1,4-disubstituted-piperidinyl compounds in the manufacture of a medicament for the treatment of insomnia
CA2049655A1 (fr) Composition pharmaceutique pour inhiber l'aggregation des plaquettes
EP0408044A3 (en) Anti-inflammatory and/or anti-allergic composition comprising glutathione derivatives
TW276997B (fr)
AU563094B2 (en) 1,5-benzothiazepine derivatives
IE901104L (en) New bronchospasmolytic compounds and process for their¹preparation
IL87107A0 (en) Naphthothiazepine derivatives,their preparation and pharmaceutical compositions containing them
TW275629B (fr)
ES8302719A1 (es) Un procedimiento para preparar compuestos de cefem
AU2587284A (en) N-(1-oxo-2,4,6-cycloheptatrienyl)-21+-1,2-benzothiazine-3- carboxamido 1,1-dioxide
IE901105L (en) Antibacterial 2-carbapenem derivatives
PT84760A (en) Heterocyclic compounds
AU5127896A (en) Substituted 6-h-1,3,4-thiadiazine-2-amines, the use thereof as an aesthetising, cardiovascular and hypometabolic agents, and a pharmaceutical composition containing them
EP0272849A3 (en) Use of 2-oxo-imidazolidine derivatives in the treatment of kidney diseases

Legal Events

Date Code Title Description
EEER Examination request
MKLA Lapsed